Yield10 Bioscience
YTEN
Yield10 Bioscience (YTEN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $6.39 M
According to Yield10 Bioscience's latest financial reports the company's total liabilities are $6.39 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Yield10 Bioscience - Total liabilities on balance sheet (from 2004 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $3.68 M | -16.04% |
| 2021-12-31 | $4.38 M | -12.04% |
| 2020-12-31 | $4.99 M | -76.01% |
| 2019-12-31 | $20.8 M | 186.46% |
| 2018-12-31 | $7.26 M | 114.85% |
| 2017-12-31 | $3.38 M | -22.81% |
| 2016-12-31 | $4.37 M | 7.86% |
| 2015-12-31 | $4.06 M | -6.43% |
| 2014-12-31 | $4.33 M | -31.56% |
| 2013-12-31 | $6.34 M | 2.76% |
| 2012-12-31 | $6.17 M | -85.8% |
| 2011-12-31 | $43.44 M | 0.82% |
| 2010-12-31 | $43.09 M | 1.38% |
| 2009-12-31 | $42.51 M | 12.3% |
| 2008-12-31 | $37.85 M | 27.02% |
| 2007-12-31 | $29.8 M | 65.49% |
| 2006-12-31 | $18 M | -66.58% |
| 2005-12-31 | $53.88 M | 15.93% |
| 2004-12-31 | $46.48 M | |
| 2002-12-31 | $3.58 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | -50.74% | Bahamas |
 NRC Health
NRC | $73.48 M | 1,049.95% | 🇺🇸 USA |